Cargando…
Patients with questionable penicillin (beta-lactam) allergy: Causes and solutions
Background: In Europe, North America, and Australia, 5% to 10% of the population are now classified as penicillin (β-lactam) allergic. Only ~ 10% of these questionable diagnoses, mostly made in childhood, can be confirmed by allergy diagnostics. Materials and methods: The aim of this review is to sh...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dustri-Verlag Dr. Karl Feistle
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822521/ https://www.ncbi.nlm.nih.gov/pubmed/35141465 http://dx.doi.org/10.5414/ALX02310E |
_version_ | 1784646621228695552 |
---|---|
author | Brockow, Knut Wurpts, Gerda Trautmann, Axel |
author_facet | Brockow, Knut Wurpts, Gerda Trautmann, Axel |
author_sort | Brockow, Knut |
collection | PubMed |
description | Background: In Europe, North America, and Australia, 5% to 10% of the population are now classified as penicillin (β-lactam) allergic. Only ~ 10% of these questionable diagnoses, mostly made in childhood, can be confirmed by allergy diagnostics. Materials and methods: The aim of this review is to show causes and consequences as well as recommendations for dealing with the often questionable diagnosis of penicillin (β-lactam) allergy (BLA). Results: An incorrect BLA diagnosis may negatively impact antibiotic treatment needed in the future, by using a less effective antibiotic or using a broad-spectrum antibiotic, for example, further exacerbating the problem of increasing antibiotic resistance. Accordingly, there is growing pressure from antibiotic stewardship programs to critically challenge the BLA diagnosis. Conservatively, a suspected BLA is reviewed by an allergist using medical history, skin testing, laboratory testing, and provocation. This clarification is costly and is not remunerated in the German health care system; that is the reason why this testing is only offered in a few specialized clinics and practically not at all in general practice. In view of thousands of affected patients, additional strategies are needed to treat patients with a low risk of hypersensitivity reaction despite suspected allergy with a β-lactam antibiotic. In recent years, various methods have been proposed to eliminate suspected allergy as promptly as possible and directly before necessary treatment with a β-lactam antibiotic, including standardized history (also in the form of an algorithm), skin test with immediate reading after 15 minutes, or administration of a small test dose. Investigations of small case series and also multi-center studies to date have yielded promising results in terms of feasibility and safety. Conclusion: Of the large number of patients with (questionable) BLA, most have never been tested and – if antibiotic treatment becomes necessary – simply receive an alternative antibiotic. The diagnosis of BLA therefore requires new approaches besides classical allergy testing to critically question BLA. |
format | Online Article Text |
id | pubmed-8822521 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dustri-Verlag Dr. Karl Feistle |
record_format | MEDLINE/PubMed |
spelling | pubmed-88225212022-02-08 Patients with questionable penicillin (beta-lactam) allergy: Causes and solutions Brockow, Knut Wurpts, Gerda Trautmann, Axel Allergol Select Review Article Background: In Europe, North America, and Australia, 5% to 10% of the population are now classified as penicillin (β-lactam) allergic. Only ~ 10% of these questionable diagnoses, mostly made in childhood, can be confirmed by allergy diagnostics. Materials and methods: The aim of this review is to show causes and consequences as well as recommendations for dealing with the often questionable diagnosis of penicillin (β-lactam) allergy (BLA). Results: An incorrect BLA diagnosis may negatively impact antibiotic treatment needed in the future, by using a less effective antibiotic or using a broad-spectrum antibiotic, for example, further exacerbating the problem of increasing antibiotic resistance. Accordingly, there is growing pressure from antibiotic stewardship programs to critically challenge the BLA diagnosis. Conservatively, a suspected BLA is reviewed by an allergist using medical history, skin testing, laboratory testing, and provocation. This clarification is costly and is not remunerated in the German health care system; that is the reason why this testing is only offered in a few specialized clinics and practically not at all in general practice. In view of thousands of affected patients, additional strategies are needed to treat patients with a low risk of hypersensitivity reaction despite suspected allergy with a β-lactam antibiotic. In recent years, various methods have been proposed to eliminate suspected allergy as promptly as possible and directly before necessary treatment with a β-lactam antibiotic, including standardized history (also in the form of an algorithm), skin test with immediate reading after 15 minutes, or administration of a small test dose. Investigations of small case series and also multi-center studies to date have yielded promising results in terms of feasibility and safety. Conclusion: Of the large number of patients with (questionable) BLA, most have never been tested and – if antibiotic treatment becomes necessary – simply receive an alternative antibiotic. The diagnosis of BLA therefore requires new approaches besides classical allergy testing to critically question BLA. Dustri-Verlag Dr. Karl Feistle 2022-02-01 /pmc/articles/PMC8822521/ /pubmed/35141465 http://dx.doi.org/10.5414/ALX02310E Text en © Dustri-Verlag Dr. K. Feistle https://creativecommons.org/licenses/by/2.5/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Brockow, Knut Wurpts, Gerda Trautmann, Axel Patients with questionable penicillin (beta-lactam) allergy: Causes and solutions |
title | Patients with questionable penicillin (beta-lactam) allergy: Causes and solutions |
title_full | Patients with questionable penicillin (beta-lactam) allergy: Causes and solutions |
title_fullStr | Patients with questionable penicillin (beta-lactam) allergy: Causes and solutions |
title_full_unstemmed | Patients with questionable penicillin (beta-lactam) allergy: Causes and solutions |
title_short | Patients with questionable penicillin (beta-lactam) allergy: Causes and solutions |
title_sort | patients with questionable penicillin (beta-lactam) allergy: causes and solutions |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822521/ https://www.ncbi.nlm.nih.gov/pubmed/35141465 http://dx.doi.org/10.5414/ALX02310E |
work_keys_str_mv | AT brockowknut patientswithquestionablepenicillinbetalactamallergycausesandsolutions AT wurptsgerda patientswithquestionablepenicillinbetalactamallergycausesandsolutions AT trautmannaxel patientswithquestionablepenicillinbetalactamallergycausesandsolutions |